Mobocertinib succinate (TAK-788 succinate) is a potent and orally active inhibitor of EGFR and HER2 oncogenic mutants, including exon 20 insertions, with selectivity over WT EGFR. Antitumor activity.
Molecular Weight:
703.78
Purity:
>99%
CAS Number:
[2389149-74-8]
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted
